| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000024329 |
| Receipt No. | R000028017 |
| Official scientific title of the study | Effect of Lumbar Traction for chronic Low Back Pain: A Cross-over Randomized Controlled Trial |
| Date of disclosure of the study information | 2016/10/13 |
| Last modified on | 2017/04/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of Lumbar Traction for chronic Low Back Pain: A Cross-over Randomized Controlled Trial | |
| Title of the study (Brief title) | Low back pain Traction Therapy (LTT) Study | |
| Region |
|
|
| Condition | |||
| Condition | Chronic low back pain | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the effects of lumber traction for chronic low back pain |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Assessment of pain: VAS
Assessment of disability: JLEQ (Japan Low-back pain Evaluation Questionnaire) and RDQ (Roland Morris Disability Ques-tionnaire) |
| Key secondary outcomes | Assessment of functional impairment: Finger- floor distance (FFD) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Tow therapy A preceding group = "test" group: The traction for 10 minutes to which the vibration function was added. It's repeated for traction 30 seconds and suspension 5 seconds.
The load of traction: 40% of the body weight. Three days a week for 1 week. And put 3 days (Saturday, Sunday, and Monday) as a washout period between 2 arms. |
|
| Interventions/Control_2 | Tow therapy B preceding group = "control" group: The traction for 10 minutes. It's repeated for traction 30 seconds and suspension 5 seconds.
The load of traction: 40% of the body weight. Three days a week for 1 week. And put 3 days (Saturday, Sunday, and Monday) as a washout period between 2 arms. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients satisfying the following conditions (1)-(4) are included.
(1) Outpatients aged 20-65 years old. Both men and women are able to join the trial. (2) Patients who have had low back pain lasting more than 3 months. The symptom is chronic and no obvious neurological deficit. A chronologic fluctuation of the pain is not considered if the pain itself continues more than 3 months. (3) Low back pain is defined as the back ache occurring between the L1 spinal process and the gluteal sulcus. (4) The patient satisfying the following conditions: 1. Leg raising angle (by SLR maneuver) is less than 70 degrees. 2. There is no sensory deterioration by a superficial sensory examination. 3. The muscle strength in the lower limb is more than 4 by the Manual Muscle Testing (MMT). 4. The FNST (femoral nerve stretch test) is negative. |
|||
| Key exclusion criteria | (1) Patient who had operation for lumbar spine in the past.
(2) Patient who had spine/spinal cord neoplasm, infection, and fracture (compression fracture) (3) Patient who had severe osteoporosis (more than the III degree in the Jikei Med. Univ. classification) (4) Patient with psychiatric disorder. (5) Patient who had a history with cerebro-vascular accident within 6 months before the day of agreement to enter the trial (6) Patient who had a history with myocardial infarction within 6 months before the day of agreement to enter the trial (7) Patient who received treatment for cardiac failure (8) Patient with liver dysfunction (9) Patient with renal dysfunction (10) Pregnant patient. |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Hiromoto Ito/ Hodeki Tanabe |
| Organization | President, The Japanese Society of Musculoskeletal Medicine
President, The Japanese Clinical Orthopaedic Association |
| Division name | The Office of the Japanese Society of Mus-culoskeletal Medicine/ The Office of the Japanese Clinical Orthopaedic Association |
| Address | c/o Department of Orthopaedic Surgery, Jichi Medical School 3311-1Yakushiji, Shimotuke-shi, 329-0498 Tochigi/ 6F, Okachimachi-Taitou Building, 4-26-8, Taitou, Taitou-ku, 110-0016 Tokyo |
| TEL | 0258-58-7374 |
| yuriko229@jichi.ac.jp | |
| Public contact | |
| Name of contact person | Masami Akai |
| Organization | International University of Health and Welfare |
| Division name | Graduate School |
| Address | 4F, Aoyama 1-Chome Tower, 1-3-3 Mina-mi-Aoyama, Minato-ku, 107-0062 Tokyo |
| TEL | 03-6406-8621 |
| Homepage URL | |
| akai-masami@iuhw.ac.jp | |
| Sponsor | |
| Institute | The Japanese Society of Musculoskeletal Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | The Japanese Clinical Orthopaedic Association |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028017 |